Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$194 Hold
7
﹤0.01% 1120
2026
Q1
$103 Hold
7
﹤0.01% 1406
2025
Q4
$89 Hold
7
﹤0.01% 1395
2025
Q3
$108 Hold
7
﹤0.01% 1298
2025
Q2
$111 Hold
7
﹤0.01% 1233
2025
Q1
$134 Sell
7
-5
-42% -$109 ﹤0.01% 1151
2024
Q4
$287 Hold
12
﹤0.01% 908
2024
Q3
$336 Sell
12
-1
-8% -$28 ﹤0.01% 951
2024
Q2
$340 Sell
13
-62
-83% -$1.29K ﹤0.01% 940
2024
Q1
$1.64K Buy
75
+61
+436% +$1.31K ﹤0.01% 702
2023
Q4
$326 Hold
14
﹤0.01% 1123
2023
Q3
$277 Hold
14
﹤0.01% 1037
2023
Q2
$318 Buy
+14
New +$282 ﹤0.01% 1022

Other funds holding RXO

Abound Wealth Management's RXO Position: Q2 2026 in Review

Abound Wealth Management held its RXO (RXO) position steady in Q2 2026 at 7 shares worth $194. The position accounts for ﹤0.01% of the portfolio, ranked #1120.

Abound Wealth Management first reported a position in RXO in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.64K in Q1 2024. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Abound Wealth Management held 7 shares of RXO worth $194 as of Q2 2026.
  • Abound Wealth Management left its RXO share count unchanged in Q2 2026.
  • RXO made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1120 holding.
  • Abound Wealth Management first reported a position in RXO in Q2 2023 and has held it in 13 quarters since.
  • Abound Wealth Management's RXO position peaked at $1.64K in Q1 2024.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.